Suvretta Capital Management »

Crinetics Pharmaceuticals In shares owned by Suvretta Capital Management

Quarter-by-quarter ownership of Crinetics Pharmaceuticals In (CRNX) shares owned by Suvretta Capital Management from 13F filings

Historical chart of Suvretta Capital Management investment in Crinetics Pharmaceuticals In

Tip: Access up to 7 years of quarterly data

All positions including Crinetics Pharmaceuticals In held by Suvretta Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Crinetics Pharmaceuticals In by Suvretta Capital Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $38M 1.0M 36.32
2022-06-30 $21M 1.1M 18.65

More positions owned by Suvretta Capital Management

Arcutis Biotherapeutics (ARQT)
Veradermics Common Stock
State Str Spdr S&p 500 Etf T Tr Unit Put Option (SPY)
Palvella Therapeutics Inc Ne (PVLA)
Apellis Pharmaceuticals (APLS)
Legend Biotech Corp Sponsored Ads (LEGN)
Benitec Biopharma Com New (BNTC)
Capricor Therapeutics Com New (CAPR)
Immatics SHS (IMTX)
Arcus Biosciences Incorporated (RCUS)
Eyepoint Com New (EYPT)
Arrivent Biopharma (AVBP)
Taiwan Semiconductor Manufac Sponsored Ads (TSM)
NVIDIA Corporation (NVDA)
Meta Platforms Cl A (META)

View all positions for Suvretta Capital Management

Top funds holding Crinetics Pharmaceuticals In

FMR
Vanguard Group
BlackRock
Wellington Management Company
Farallon Capital Management
Driehaus Capital Management
Vanguard Capital Management
Vanguard Portfolio Management
Henderson Group
EcoR1 Capital
Geode Capital Management
Baker Bros. Advisors
State Street Corporation
Pictet Asset Management Holding SA
Jennifer Ranahan

View all funds holding Crinetics Pharmaceuticals In